Longevity Health Holdings, Inc.
XAGE
$0.30
$0.0311.94%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.06% | -15.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.06% | -15.43% | |||
| Cost of Revenue | 12.48% | -3.13% | |||
| Gross Profit | 9.82% | -23.62% | |||
| SG&A Expenses | 63.29% | -22.47% | |||
| Depreciation & Amortization | 0.00% | -26.58% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 43.64% | -18.71% | |||
| Operating Income | -52.92% | 19.60% | |||
| Income Before Tax | -43.17% | 24.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -45.70% | 24.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -45.70% | 24.20% | |||
| EBIT | -52.92% | 19.60% | |||
| EBITDA | -53.50% | 19.52% | |||
| EPS Basic | -40.63% | 46.80% | |||
| Normalized Basic EPS | -38.44% | 43.59% | |||
| EPS Diluted | -40.63% | 46.80% | |||
| Normalized Diluted EPS | -38.44% | 43.59% | |||
| Average Basic Shares Outstanding | 3.61% | 42.45% | |||
| Average Diluted Shares Outstanding | 3.61% | 42.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||